E-LIB Suche - Ergebnisse für: Nicolas Pelisch

1

Use of a Self-Delivering Anti-CCL3 FANA Oligonucleotide as ..:

Pelisch, Nicolas ; Rosas Almanza, Jose ; Stehlik, Kyle E...
eneuro. 8 (2021) 2 - p. ENEURO.0338-20.2021 , 2021

Link: https://doi.org/10.1523/..

2

Correction to: CCL3 contributes to secondary damage after s..:

Pelisch, Nicolas ; Almanza, Jose Rosas ; Stehlik, Kyle E...
Journal of Neuroinflammation. 18 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

3

CCL3 contributes to secondary damage after spinal cord inju..:

Pelisch, Nicolas ; Rosas Almanza, Jose ; Stehlik, Kyle E...
Journal of Neuroinflammation. 17 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

4

The toll-like receptor 2 agonist Pam3CSK4 is neuroprotectiv..:

Stivers, Nicole S. ; Pelisch, Nicolas ; Orem, Ben C....
Experimental Neurology. 294 (2017) - p. 1-11 , 2017

Link: https://doi.org/10.1016/..

5

Intracellular calcium release through IP 3 R or RyR contrib..:

Orem, Ben C. ; Pelisch, Nicolas ; Williams, Joshua..
Neurobiology of Disease. 106 (2017) - p. 235-243 , 2017

Link: https://doi.org/10.1016/..

6

Differential expression of ryanodine receptor isoforms afte..:

Pelisch, Nicolas ; Gomes, Cynthia ; Nally, Jacqueline M...
Neuroscience Letters. 660 (2017) - p. 51-56 , 2017

Link: https://doi.org/10.1016/..

7

Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenua..:

Pelisch, Nicolas ; Dan, Takashi ; Ichimura, Atsuhiko...
PLOS ONE. 10 (2015) 4 - p. e0124510 , 2015

Link: https://doi.org/10.1371/..

8

Angiotensin-Converting Enzyme Inhibitor Does Not Suppress R..:

Ohnishi, Keisuke ; Murase, Miki ; Nakano, Daisuke...
Journal of Pharmacological Sciences. 122 (2013) 2 - p. 103-108 , 2013

Link: https://doi.org/10.1254/..

9

Effects of Angiotensin II AT1^|^ndash;Receptor Blockade on ..:

Kosaka, Shinji ; Pelisch, Nicolas ; Rahman, Matlubur...
Journal of Pharmacological Sciences. 121 (2013) 2 - p. 95-102 , 2013

Link: https://doi.org/10.1254/..

10

Possible contribution of the non‐proteolytic activation of ..:

Nagai, Yukiko ; Ichihara, Atsuhiro ; Nakano, Daisuke...
Experimental Physiology. 94 (2009) 9 - p. 1016-1023 , 2009

Link: https://doi.org/10.1113/..

11

Correction to: CCL3 contributes to secondary damage after s..:

Nicolas Pelisch ; Jose Rosas Almanza ; Kyle E. Stehlik..
https://doi.org/10.1186/s12974-021-02128-9. , 2021

Link: https://doi.org/10.1186/..

12

CCL3 contributes to secondary damage after spinal cord inju..:

Nicolas Pelisch ; Jose Rosas Almanza ; Kyle E. Stehlik..
https://doi.org/10.1186/s12974-020-02037-3. , 2020

Link: https://doi.org/10.1186/..

13

Intracellular calcium release through IP3R or RyR contribut..:

Ben C. Orem ; Nicolas Pelisch ; Joshua Williams..
http://www.sciencedirect.com/science/article/pii/S096999611730164X. , 2017

Link: https://doi.org/10.1016/..

14

Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenua..:

Nicolas Pelisch ; Takashi Dan ; Atsuhiko Ichimura...
http://europepmc.org/articles/PMC4411110?pdf=render. , 2015

Link: https://doi.org/10.1371/..

15

Effects of Angiotensin II AT1–Receptor Blockade on High Fat..:

Shinji Kosaka ; Nicolas Pelisch ; Matlubur Rahman...
http://www.sciencedirect.com/science/article/pii/S1347861319303846. , 2013

Link: https://doi.org/10.1254/..